Zynex Inc (OQ:ZYXI)

Business Focus: Advanced Medical Equipment & Technology

Feb 22, 2024 08:15 am ET
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
ENGLEWOOD, Colo., Feb. 22, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, February 29, 2024 at 4:15 PM Eastern Time to discuss its financial results for the fourth quarter and full year ended December 31, 2023. Financial results will be issued in a press release prior to the call.
Feb 20, 2024 08:15 am ET
Zynex Introduces New Products
ENGLEWOOD, Colo., Feb. 20, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, introduced two new therapy products: the Zynex Pro Hybrid LSO and the Zynex DynaComp Cold Compression.
Feb 08, 2024 09:00 am ET
Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023
Today, Sichenzia Ross Ference Carmel LLP (“SRFC”), a full-service law firm internationally recognized for its securities and litigation practices, announced that it has closed over 100 transactions, ranging from $1.1 million to $70 million. In...
Feb 06, 2024 08:15 am ET
Zynex Receives FDA Clearance for its Next Generation NMES Device
ENGLEWOOD, Colo., Feb. 6, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has received clearance from the U.S. Food and Drug Administration ("FDA") for the next generation M-Wave Neuromuscular Electrical Stimulation ("NMES") device.
Feb 02, 2024 08:15 am ET
Zynex Recognized in Top 25 Medical Device Companies for 2024
ENGLEWOOD, Colo., Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report recognized Zynex as 9th amongst the Top 25 Medical Device Companies for 2024.
Jan 08, 2024 08:15 am ET
Zynex to Participate at the Needham Annual Growth Conference
ENGLEWOOD, Colo., Jan. 8, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will participate virtually in the upcoming Needham Annual Growth Conference, which is being held January 16th-19th, 2024.
Nov 15, 2023 08:15 am ET
Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024"
ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. The 2024 Forbes list of America's Most Successful Small-Cap Companies can be found at www.forbes.com.
Nov 13, 2023 08:15 am ET
Zynex Submits FDA Application for its Next Generation NMES Device
ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device.
Nov 09, 2023 08:15 am ET
Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year
ENGLEWOOD, Colo., Nov. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked among all companies in the U.S. and Canada between 2019 and 2022 on Deloitte's Technology Fast 500. Zynex's revenues grew 248% over that period, with 2022 revenue reaching $158.2 million. The company estimates 2023 revenue between $189.5 and $194.5 million. The 2023 Deloitte Technology Fast 500 list can
Nov 01, 2023 09:15 am ET
Zynex Announces Share Repurchase Program
ENGLEWOOD, Colo., Nov. 1, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to repurchase up to $20.0 million of the Company's common stock. The program will commence on November 1, 2023, and is scheduled to terminate on the earlier of November 1, 2024, or when the $20.0 million limit is reached.
Oct 31, 2023 06:45 am ET
Zynex Announces Review of Strategic Alternatives
ENGLEWOOD, Colo., Oct. 31, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced its Board of Directors (the "Board") has initiated a process to evaluate potential strategic alternatives to maximize shareholder value.  As part of the process, the Board will evaluate, together with its advisors, a range of potential strategic alternatives which may include, any take private offers, a sale, merger or other busi
Oct 26, 2023 04:01 pm ET
Zynex Reports Third Quarter 2023 Financial Results
Q3 2023 Revenue Increased 20% to $49.9 Million; EPS $0.10
Oct 19, 2023 09:15 am ET
Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row
ENGLEWOOD, Colo., Oct. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report has recognized Zynex as 23rd in the Top 100 Healthcare Technology Companies of 2023. 2023 is the second year Zynex has been included within the report's top 100. Last year, Zynex ranked as the 33rd company.
Oct 12, 2023 09:15 am ET
Zynex, Inc Sets Third Quarter 2023 Earnings Call
ENGLEWOOD, Colo., Oct. 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 26, 2023 at 4:15 PM Eastern Time to discuss its financial results for the third quarter ended September 30, 2023.  Financial results will be issued in a press release prior to the call.
Sep 19, 2023 09:15 am ET
Zynex to Present at the Cantor Global Healthcare Conference
ENGLEWOOD, Colo., Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming Cantor Global Healthcare Conference, which is being held September 26th-28th, 2023.
Sep 11, 2023 09:15 am ET
Zynex Announces Share Repurchase Program
ENGLEWOOD, Colo., Sept. 11, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to repurchase $10.0 million of the Company's common stock. The program will commence on September 13, 2023, and is scheduled to terminate on September 12, 2024, or when the $10.0 million limit is reached.
Jul 27, 2023 04:01 pm ET
Zynex Reports Second Quarter 2023 Financial Results
Q2 2023 Revenue increased 22% to $45.0 Million; EPS $0.09
Jul 20, 2023 09:15 am ET
Zynex, Inc. Sets Second Quarter 2023 Earnings Call
ENGLEWOOD, Colo., July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 27, 2023 at 4:15 PM Eastern Time to discuss its financial results for the second quarter, 2023 ended June 30, 2023. Financial results will be issued in a press release prior to the call.
Jul 17, 2023 09:15 am ET
Zynex, Inc. (NASD: ZYXI) Wins 2023 National Top Workplaces Award in the Manufacturing Industry Category
ENGLEWOOD, Colo., July 17, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has won the Top Workplace Award among manufacturers, given by Energage, LLC, an employee engagement technology partner. Winners are chosen based on an anonymous third-party employee survey that measures several aspects of workplace culture, including alignment, execution, and connection.
Jul 12, 2023 09:15 am ET
Zynex Reports Preliminary Second Quarter 2023 Results
ENGLEWOOD, Colo., July 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2023 and reiterated full-year guidance.
Jul 10, 2023 09:15 am ET
Zynex, Inc. Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
ENGLEWOOD, Colo., July 10, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has engaged international investor relations specialists MZ Group ("MZ") to lead their comprehensive strategic investor relations and financial communications program across all key markets.
Jun 20, 2023 09:15 am ET
Zynex Receives FDA Clearance of CM-1600 Monitor for Improved Blood and Fluid Management
ENGLEWOOD, Colo., June 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the FDA (Food and Drug Administration) has granted 510(k) market clearance for the company's CM-1600 blood and fluid volume monitoring device.  
May 04, 2023 09:04 pm ET
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
ENGLEWOOD, Colo., May 4, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), announced today the pricing of its previously announced private offering of $52.5 million aggregate principal amount of 5.00% convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Notes Offering was upsized from the previously announced offering size of $50.0 million aggregate principal amount of Notes.  In add
May 04, 2023 07:30 am ET
Zynex Announces Update Regarding Previously Announced Offerings
ENGLEWOOD, Colo., May 4, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced that Thomas Sandgaard, its Chief Executive Officer (the "Selling Stockholder"), has determined not to pursue the public offering of 2,000,000 shares of the Company's common stock that was previously announced on May 3, 2023 (the "Secondary Offering"). The decision results from an assessment by the Selling Stockholder that current market conditions are not conducive to this offering on terms that would be in the best interests of the Selling Stockholder.  As a result of such termination, no sha
May 03, 2023 04:02 pm ET
Zynex Announces Proposed Secondary Public Offering of Common Stock
ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex" or "the Company") (Nasdaq: ZYXI), today announced the commencement of an underwritten public offering of 2,000,000 shares of its common stock by Thomas Sandgaard, its Chief Executive Officer (the "Secondary Offering").  Mr. Sandgaard also intends to grant the underwriter a 30-day option to purchase up to an additional 300,000 shares of the Company's common stock. The Secondary Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Secondary Offering may be completed. Zynex
May 03, 2023 04:01 pm ET
Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million aggregate principal amount of its convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Zynex also intends to grant the initial purchaser of the Notes an option to purchase, for settlement within a 13-day period beginni
May 03, 2023 09:15 am ET
Zynex Named as a Winner of Colorado's Top Workplaces 2023 by The Denver Post
ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has been named by The Denver Post as a winner of Colorado's Top Workplaces 2023 Award.  
Apr 27, 2023 04:01 pm ET
Zynex Announces 2023 First Quarter Earnings
ENGLEWOOD, Colo., April 27, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the first quarter ended March 31, 2023.
Apr 19, 2023 09:15 am ET
Zynex, Inc. to Announce First Quarter 2023 Financial Results
ENGLEWOOD, Colo., April 19, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report first quarter 2023 financial results on Thursday, April 27, 2023. Zynex's management will host a conference call and webcast at 2:15 p.m. MT / 4:15 p.m. ET that day to discuss the financial results and provide a corporate update.
Apr 11, 2023 09:15 am ET
Zynex Reports Preliminary First Quarter 2023 Results
ENGLEWOOD, Colo., April 11, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for first quarter 2023 and reiterated full year guidance.
Apr 07, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Veradigm, LivePerson, First Republic, and Zynex and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Veradigm Inc. (NASDAQ: MDRX), LivePerson, Inc. (NASDAQ: LPSN), First Republic Bank (NYSE: FRC), and Zynex, Inc. (NASDAQ:...
Apr 06, 2023 09:15 am ET
Zynex Earns Spot on Financial Times List of "The Americas' Fastest-Growing Companies 2023" for Second Consecutive Year
ENGLEWOOD, Colo., April 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has been ranked 191 out of 500 on The Financial Times fourth annual list of The Americas' Fastest Growing Companies 2023.
Apr 05, 2023 06:02 pm ET
ZYXI INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Zynex (ZYXI) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Delayed Earnings Report and Possi
Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: [email protected]          844-916-0895 Zynex, Inc. (ZYXI)...
Apr 03, 2023 10:20 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zynex, Inc. - ZYXI
NEW YORK, April 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Mar 30, 2023 11:00 pm ET
ZYNEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Zynex Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of Zynex stockholders. Our investigation concerns whether Zynex has violated the federal securities laws and/or engaged in other unlawful business practices.
Mar 29, 2023 12:20 pm ET
Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Zynex, Inc. (ZYXI)
The law firm of Kirby McInerney LLP is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ:
Mar 29, 2023 11:43 am ET
ZYXI INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Zynex (ZYXI) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Delayed Earnings Report and Poss
Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: [email protected]...
Mar 24, 2023 06:21 pm ET
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Zynex, Inc. Investors to Inquire About Class Action Investigation – ZYXI
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zynex, Inc. (NASDAQ: ZYXI) resulting from allegations that Zynex may have issued materially misleading...
Mar 22, 2023 07:10 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zynex, Inc. - ZYXI
NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Mar 21, 2023 09:15 am ET
Zynex Included in Denver-Area's Top 10 Biotechnology/Bioscience Companies
ENGLEWOOD, Colo., March 21, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Denver Business Journal has ranked Zynex sixth in a list of the largest Denver-area Biotechnology/Bioscience companies, according to the number of full-time employees (FTEs).
Mar 20, 2023 07:08 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zynex, Inc. - ZYXI
Pomerantz LLP is investigating claims on behalf of investors of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Mar 20, 2023 09:07 am ET
ZYXI INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Zynex (ZYXI) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Delayed Earnings Report and Poss
Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: [email protected]...
Mar 15, 2023 06:52 pm ET
ROSEN, A LEADING NATIONAL FIRM, Encourages Zynex, Inc. Investors to Inquire About Class Action Investigation – ZYXI
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zynex, Inc. (NASDAQ: ZYXI) resulting from allegations that Zynex may have issued materially misleading...
Mar 15, 2023 04:57 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Zynex (ZYXI) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Delayed Earnings Report and Possible Securities Law V
Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: [email protected]...
Mar 13, 2023 08:00 am ET
Zynex Announces 2022 Fourth Quarter and Full Year Earnings
ENGLEWOOD, Colo., March 13, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022.
Mar 12, 2023 08:30 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zynex, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / March 12, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI) for violations of the securities laws.
Mar 10, 2023 06:20 pm ET
Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Zynex, Inc. (ZYXI)
The law firm of Kirby McInerney LLP is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI). The investigation concerns whether Zynex and/or certain of its officers have violated the federal securities laws...
Mar 09, 2023 12:33 pm ET
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Zynex, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – ZYXI
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zynex, Inc. (NASDAQ: ZYXI) resulting from allegations that Zynex may have issued materially misleading business information to the investing public.
Mar 09, 2023 12:00 pm ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zynex, Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zynex, Inc. (“Zynex” or “the Company”) (NASDAQ:
Mar 09, 2023 12:00 pm ET
Zynex, Inc. (ZYXI): Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm advises Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Zynex investors that lost...
Mar 08, 2023 04:43 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Zynex (ZYXI) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Delayed Earnings Report and Possible Securities Law V
Hagens Berman urges Zynex, Inc. (NASDAQ: ZYXI) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/ZYXI Contact An Attorney Now: [email protected]...
Mar 08, 2023 03:39 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zynex, Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zynex, Inc. (“Zynex” or “the Company”) (NASDAQ:
Mar 08, 2023 02:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Zynex, Inc. (ZYXI) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ:
Mar 08, 2023 01:26 pm ET
Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Zynex, Inc. (ZYXI)
The law firm of Kirby McInerney LLP is investigating potential claims against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI). The investigation concerns whether Zynex and/or certain of its officers have violated the federal securities laws...
Mar 08, 2023 12:30 pm ET
Investigation of Zynex, Inc. (ZYXI) Announced by Holzer & Holzer, LLC
Holzer & Holzer, LLC is investigating whether Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) complied with federal securities laws. On March 6, 2023, Zynex announced it was postponing “the release of its fourth quarter and full year...
Mar 08, 2023 10:00 am ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Zynex, Inc. (ZYXI) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company’s possible violations of federal securities laws.
Mar 07, 2023 08:17 pm ET
Zynex, Inc. Shareholder News: Johnson Fistel Encourages Zynex, Inc. Shareholders with Losses to Contact the Firm Regarding Class Action Investigation
Shareholder rights law firm Johnson Fistel, LLP is investigating whether Zynex, Inc. (NASDAQ: ZYXI) investors' losses may be recovered under the federal securities laws. What if I purchased Zynex common stock? If you purchased Zynex common stock...
Mar 07, 2023 07:50 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Zynex, Inc. (ZYXI) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ:
Feb 17, 2023 08:28 am ET
Zynex Announces Inclusion in MSCI USA Small Cap Index
ENGLEWOOD, Colo., Feb. 17, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it is set to join the MSCI USA Small Cap Index according to the list of additions posted by MSCI on February 9, 2023. Inclusion in the index will take effect after the market close on February 28, 2023.
Feb 01, 2023 08:15 am ET
Zynex Monitoring Announces Community Blood Drive and Research Collaboration Trial for its Fluid Monitoring System
ENGLEWOOD, Colo., Feb. 1, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today reported it will be hosting a blood donation drive on February 1, 2023 at its headquarters in Englewood, CO in partnership with Vitalant, the nation's largest independent, nonprofit blood services provider. The drive will fulfill an important and immediate need to help with the emergency shortage of blood in the community while also offering
Jan 31, 2023 08:15 am ET
Zynex Recognized in The Power 500 Healthcare Technology Companies
ENGLEWOOD, Colo., Jan. 31, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report has recognized Zynex in The Power 500 Healthcare Technology Companies. 
Jan 17, 2023 08:15 am ET
Zynex Reports Preliminary Fourth Quarter 2022 Results
ENGLEWOOD, Colo., Jan. 17, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for fourth quarter 2022 and reiterated full year guidance.
Dec 22, 2022 08:15 am ET
Zynex Ranks 11th in Forbes List of "America's Best Small Companies 2023"
ENGLEWOOD, Colo., Dec. 22, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been ranked 11th on Forbes list of America's Best Small Companies for 2023. The 2023 Forbes list of America's Best Small Companies can be found at www.forbes.com.
Nov 21, 2022 08:15 am ET
Zynex Medical to Participate in Piper Sandler 34th Annual Healthcare Conference
ENGLEWOOD, Colo., Nov. 21, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the Company's management will participate in the Piper Sandler 34th Annual Healthcare Conference. Interested parties can access the webcast on the Events section of the website at https://zynexmed.investorroom.com/ir-home on Wednesday, November 30th, 2022, at 4:30 pm ET.
Nov 17, 2022 08:15 am ET
Zynex Named as a Winner in the Deloitte 2022 Technology Fast 500TM Awards for the 4th Consecutive Year
ENGLEWOOD, Colo., Nov. 17, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been ranked 416th in revenue growth among all companies in the U.S. and Canada for revenue growth between 2018 and 2021 on Deloitte's Technology Fast 500. Zynex's revenues grew 308% over that period, with 2021 revenue reaching $130.3 million.  The company estimates 2022 revenue between $157.4 and $160.4 million. The 2022 D
Nov 01, 2022 09:15 am ET
Zynex Announces Additional Share Buyback Program
ENGLEWOOD, Colo., Nov. 1, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock. The program will commence on November 1, 2022 and is scheduled to terminate on October 31, 2023 or when the $10.0 million buyback limit is reached.
Oct 27, 2022 04:02 pm ET
Zynex Announces 2022 Third Quarter Earnings
ENGLEWOOD, Colo., Oct. 27, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the third quarter ended September 30, 2022.
Oct 13, 2022 09:15 am ET
Zynex, Inc. to Announce Third Quarter 2022 Financial Results
ENGLEWOOD, Colo., Oct. 13, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report third quarter 2022 financial results on Thursday, October 27, 2022. Zynex's management will host a conference call and webcast at 4:15 p.m. ET that day to discuss the financial results and provide a corporate update.
Oct 11, 2022 09:15 am ET
Zynex Reports Preliminary Third Quarter 2022 Results
ENGLEWOOD, Colo., Oct. 11, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for third quarter 2022 and reiterated full year guidance.
Sep 21, 2022 09:15 am ET
Zynex Monitoring Solutions Announces First Enrollment in a Blood Loss Detection Clinical Trial for its CM-1600 Monitoring System
ENGLEWOOD, Colo., Sept. 21, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today announced it has begun enrollments in a large-scale blood loss detection clinical trial with its second-generation monitoring system, the CM-1600. 
Sep 01, 2022 09:15 am ET
Zynex Medical to Participate in H.C. Wainwright Annual Global Investment Conference
ENGLEWOOD, Colo. , Sept. 1, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the Company's management will participate virtually in the H.C. Wainwright Annual Global Investment Conference. Interested parties can access the webcast on the Events section of the website at https://zynexmed.investorroom.com/ir-home on Monday, September 12th, 2022, at 7am ET.
Aug 23, 2022 09:15 am ET
Zynex Medical to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase
ENGLEWOOD, Colo., Aug. 23, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the Company's management will participate virtually in the Gilmartin Group Emerging Growth Company Showcase on August 31st, 2022 at 11:00 am ET. Interested parties can access the live and archived webcast at https://zynexmed.investorroom.com/ir-home.
Aug 15, 2022 09:15 am ET
Zynex Announces First Enrollments in Apheresis Donation Clinical Trial with Second Generation Fluid Monitoring System
ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has started enrollments in an ongoing apheresis clinical trial with its second-generation fluid monitoring system, the CM-1600.
Aug 08, 2022 09:00 am ET
Zynex Recognized in Top 100 Healthcare Technology Companies of 2022
ENGLEWOOD, Colo., Aug. 8, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare Technology Report has recognized Zynex as 33rd in the Top 100 Healthcare Technology Companies of 2022. 
Aug 03, 2022 09:00 am ET
Zynex Ranked in Top 50 Public Companies in Colorado
ENGLEWOOD, Colo., Aug. 3, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Denver Business Journal has ranked Zynex number 50 in a list Colorado-based public companies, according to 2021 revenue figures.
Jul 28, 2022 04:01 pm ET
Zynex Announces 2022 Second Quarter Earnings
ENGLEWOOD, Colo., July 28, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the second quarter ended June 30, 2022.
Jul 20, 2022 09:15 am ET
Zynex, Inc. to Announce Second Quarter 2022 Financial Results
ENGLEWOOD, Colo. , July 20, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report second quarter 2022 financial results on Thursday, July 28, 2022. Zynex's management will host a conference call and webcast at 4:15 p.m. ET that day to discuss the financial results and provide a corporate update.
Jul 11, 2022 07:00 am ET
Zynex Reports Preliminary Second Quarter 2022 Results and Reiterates Full Year Revenue and EBITDA Guidance
ENGLEWOOD, Colo.  , July 11, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2022 and reiterated full year guidance.
Jun 13, 2022 04:30 pm ET
Zynex Announces Change of Auditor
ENGLEWOOD, Colo., June 13, 2022 /PRNewswire/ -- Zynex, Inc. ("Zynex or the "Company) (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has changed its auditors from Plante & Moran, PLLC ("Plante Moran") as the Company's independent registered accounting firm to Marcum LLP effective June 13, 2022. The appointment of Marcum LLP was made after careful consideration and an evaluation process by the Company and approved by the Boa
Jun 09, 2022 09:00 am ET
Zynex Announces Additional Share Buyback Program
ENGLEWOOD, Colo., June 9, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock. The program will commence on June 10, 2022 and is scheduled to terminate on June 9, 2023 or when the $10.0 million buyback limit is reached.
May 10, 2022 07:00 am ET
Zynex Medical to Participate in Upcoming Investor Conferences
ENGLEWOOD, Colo., May 10, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it will participate in two upcoming investor conferences.
May 03, 2022 07:00 am ET
Zynex Ranks 250 in Financial Times List of "The Americas' Fastest Growing Companies 2022"
ENGLEWOOD, Colo., May 3, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, ranked 250 out of 500 on The Financial Times list of Americas' Fastest Growing Companies in 2022.
Apr 28, 2022 04:01 pm ET
Zynex Announces 2022 First Quarter Earnings
ENGLEWOOD, Colo., April 28, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the first quarter ended March 31, 2022.
Apr 18, 2022 07:00 am ET
Zynex, Inc. to Announce First Quarter 2022 Financial Results
ENGLEWOOD, Colo., April 18, 2022 /PRNewswire/ -- April 18, 2022 – Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report first quarter 2022 financial results on Thursday, April 28, 2022. Zynex's management will host a conference call and webcast at 4:15 p.m. ET that day to discuss the financial results and provide a corporate update.
Apr 11, 2022 09:15 am ET
Zynex Announces Share Buyback Program
ENGLEWOOD, Colo., April 11, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the Company's common stock.  The program will commence on April 12, 2022 and is scheduled to terminate on April 11, 2023 or when the $10.0 million buyback limit is reached.
Apr 08, 2022 07:00 am ET
Zynex Reports Preliminary First Quarter 2022 Results and Provides Business Update
ENGLEWOOD, Colo., April 8, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for first quarter 2022, affirming guidance for revenue, EBITDA and order growth.
Mar 23, 2022 07:01 am ET
Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado
ENGLEWOOD, Colo., March 23, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Denver Business Journal has recognized Zynex as the fourth largest Biotechnology/Bioscience public company in Colorado based on number of companywide employees as of November 1, 2021.
Feb 24, 2022 03:01 pm ET
Zynex Announces 2021 Fourth Quarter and Full Year Earnings
ENGLEWOOD, Colo., Feb. 24, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2021.
Feb 18, 2022 06:00 am ET
Zynex Anticipates No Material Change in Revenue from Switch in United Health Care Prescription Coverage
ENGLEWOOD, Colo., Feb. 18, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today responded to a short report related to United Health Care's prescription coverage of its products.   
Feb 08, 2022 03:04 pm ET
Zynex, Inc. to Announce Fourth Quarter 2021 Financial Results
ENGLEWOOD, Colo., Feb. 8, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report fourth quarter and full-year 2021 financial results on Thursday, February 24, 2022. Zynex's management will host a conference call and webcast at 2:15 p.m. MT / 4:15 p.m. ET that day to discuss the financial results and provide a corporate update.
Jan 20, 2022 06:04 am ET
Zynex Adds Knee Bracing to Its Pain Management Division
ENGLEWOOD, Colo., Jan. 20, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is adding post-operative and OA (Osteoarthritis) knee braces to its line of pain and rehabilitation products.
Jan 18, 2022 08:00 am ET
Zynex Announces Increased Q4 2021 Adjusted EBITDA Estimate and 18% Order Growth
ENGLEWOOD, Colo., Jan. 18, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today announced order growth and an increased Adjusted EBITDA estimate for Q4 2021.
Jan 11, 2022 08:00 am ET
Zynex Monitoring Announces First Enrollment in an Apheresis Blood Donation Clinical Trial for its Fluid Monitoring System
ENGLEWOOD, Colo., Jan. 11, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today reported it has started enrollments in a clinical trial aimed at further characterizing the performance of its fluid monitoring system, CM-1500.  The study, conducted at Vitalant Research Institute (the research arm of Vitalant, the nation's largest independent, nonprofit blood services provider), tracks changes in the device's patented Rel
Jan 05, 2022 08:00 am ET
Zynex Files Utility Patent for Sepsis Monitor
ENGLEWOOD, Colo., Jan. 5, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today reported it has filed for a utility patent for its multi-parameter, noninvasive sepsis monitor. This submission follows a provisional patent application on sepsis monitoring the Company filed in January 2021.
Jan 03, 2022 08:00 am ET
Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
ENGLEWOOD, Colo., Jan. 3, 2022 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the CM-1600, its next generation fluid monitoring system.   
Dec 23, 2021 08:00 am ET
Zynex Announces Acquisition of Kestrel Labs
ENGLEWOOD, Colo., Dec. 23, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has acquired 100% of Kestrel Labs, Inc., a laser-based, noninvasive patient monitoring technology company. Kestrel Labs' laser-based products include the NiCO™ CO-Oximeter, a multi-parameter pulse oximeter, and HemeOx™, a total hemoglobin oximeter that enables continuous arterial blood monitoring. Both NiCO and HemeOx are yet t
Dec 20, 2021 08:15 am ET
Zynex Monitoring Announces First Enrollment in a Hemodialysis Clinical Trial for its Fluid Monitoring System
ENGLEWOOD, Colo., Dec. 20, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, today reported it has started enrollments in a hemodialysis clinical trial with its fluid monitoring system, CM-1500.  The study, conducted at DaVita Clinical Research clinics, is aimed at further characterizing changes in the device's patented Relative Index during hemodialysis procedures where a large volume of fluid is removed from patients. 
Nov 24, 2021 03:05 pm ET
Zynex to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
ENGLEWOOD, Colo., Nov. 24, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the company will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 22nd to December 2nd. The company will be participating in 1X1 meetings from November 29th- Decemb
Nov 18, 2021 08:15 am ET
Zynex Ranked 7th in Revenue Growth Among Medical Device Companies
ENGLEWOOD, Colo., Nov. 18, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 7th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte's 2021 Technology Fast 500.  Zynex was ranked 459th for revenue growth between 2017 and 2020 across all companies in North America.  Zynex's revenues grew 242% over that period, with 2020 r
Nov 10, 2021 08:15 am ET
Zynex Declares Special Cash Dividend of $0.10 Per Share and 10% Stock Dividend
ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has declared a one-time special cash dividend of $0.10 per share and a stock dividend of 10% per share. Both dividends are on its Common Stock. The dividends are payable to all common stockholders of record as of the close of business on January 6, 2022, payable on or about January 21, 2022. Bas
Nov 03, 2021 09:15 am ET
Zynex Celebrates 25th Anniversary
ENGLEWOOD, Colo., Nov. 3, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced its 25th anniversary.
Nov 02, 2021 04:01 pm ET
Zynex Announces 2021 Third Quarter Earnings
ENGLEWOOD, Colo., Nov. 2, 2021 /PRNewswire/ --
Oct 25, 2021 09:15 am ET
Zynex Schedules 2021 Third Quarter Earnings Call
ENGLEWOOD, Colo., Oct. 25, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2021 third quarter earnings investor webcast on Tuesday, November 2, 2021 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Oct 13, 2021 09:15 am ET
Zynex Announces 70% Order Growth and Increases Q3 2021 Adjusted EBITDA Estimate
ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q3 2021.
Oct 08, 2021 09:15 am ET
Zynex to Display its CM-1500 Fluid Monitoring System at the American Society of Anesthesiologists Annual Conference
ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that Zynex Monitoring Solutions will attend and display the CM-1500 Fluid Management Device at the American Society of Anesthesiologists Annual Conference from October 8 – 12 in San Diego.  
Jul 29, 2021 04:01 pm ET
Zynex Announces 2021 Second Quarter Earnings
ENGLEWOOD, Colo., July 29, 2021 /PRNewswire/ --
Jul 21, 2021 09:15 am ET
Zynex Schedules 2021 Second Quarter Earnings Call
ENGLEWOOD, Colo., July 21, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2021 second quarter earnings investor webcast on Thursday, July 29, 2021 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Jul 15, 2021 09:15 am ET
Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate
ENGLEWOOD, Colo., July 15, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased Adjusted EBITDA estimate for Q2 2021.
Jul 13, 2021 09:15 am ET
Zynex Announces Uplisting to the Nasdaq Global Select Market®
ENGLEWOOD, Colo., July 13, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that effective as of market open on July 14, 2021, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol "ZYXI."
Jul 08, 2021 09:15 am ET
Zynex to Present at the Ladenburg Thalmann Virtual Annual Healthcare Conference
ENGLEWOOD, Colo., July 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that Dan Moorhead, Chief Financial Officer of Zynex will present virtually at the Ladenburg Thalmann Annual Healthcare Conference on Tuesday, July 13, 2021.  Mr. Moorhead will also meet with members of the investment community during one-on-one meetings at the conference.  
Feb 25, 2021 03:01 pm ET
Zynex Announces 2020 Fourth Quarter and Full Year Earnings
ENGLEWOOD, Colo., Feb. 25, 2021 /PRNewswire/ --
Feb 18, 2021 08:15 am ET
Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call
ENGLEWOOD, Colo., Feb. 18, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2020 fourth quarter and full-year earnings investor webcast on Thursday, February 25, 2021 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Jan 28, 2021 03:30 pm ET
Zynex Appoints Anna Lucsok as Chief Operating Officer of Zynex Medical
ENGLEWOOD, Colo., Jan. 28, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has promoted Anna Lucsok to Chief Operating Officer (COO) of Zynex Medical, its pain management division. Joseph Papandrea previously held the position of COO. 
Jan 14, 2021 08:15 am ET
Zynex Announces Filing of Patent for Sepsis Monitor
ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported it has filed for a provisional patent for a noninvasive sepsis monitor.
Jan 12, 2021 08:00 am ET
Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate
ENGLEWOOD, Colo., Jan. 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q4 2020.
Jan 06, 2021 08:15 am ET
Zynex Announces a Second Utility Patent for Its Blood Volume Monitor
ENGLEWOOD, Colo., Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported it has obtained a second U.S. Utility patent for its Blood Volume Monitor Device. Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.
Nov 19, 2020 08:15 am ET
Zynex Ranked 13th in Revenue Growth Among Medical Device Companies
ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 13th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte's 2020 Technology Fast 500.  Zynex was ranked 388th for revenue growth between 2016 and 2019 across all companies in North America.  Zynex's revenues grew 242% over that period, with 2019
Nov 17, 2020 08:15 am ET
Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Company will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3. The Company will be participating in 1X1 meetings from December 1st-3rd, meeting
Oct 27, 2020 04:01 pm ET
Zynex Announces Third Quarter 2020 Earnings
ENGLEWOOD, Colo., Oct. 27, 2020 /PRNewswire/ --
Oct 23, 2020 09:15 am ET
Zynex Appoints Neil Friery as President and Chief Operating Officer of Monitoring Solutions Division
ENGLEWOOD, Colo., Oct. 23, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has hired Neil Friery as the President and Chief Operating Officer (COO) of its Monitoring Solutions Division. As President and COO, Neil will lead operations, sales, marketing and product development of the Monitoring Solution Division including the production and launch of the CM-1500 Bloo
Oct 20, 2020 09:15 am ET
Zynex Schedules 2020 Third Quarter Earnings
ENGLEWOOD, Colo., Oct. 20, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2020 third quarter earnings investor webcast on Tuesday, October 27, 2020 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Aug 31, 2020 05:00 pm ET
(LD Micro) 360 Companies Set to Present - this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Jul 28, 2020 04:01 pm ET
Zynex Announces Second Quarter 2020 Earnings
ENGLEWOOD, Colo., July 28, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended June 30, 2020.
Jul 23, 2020 09:21 am ET
Zynex Schedules 2020 Second Quarter Earnings
ENGLEWOOD, Colo., July 23, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2020 second quarter earnings investor webcast on Tuesday, July 28, 2020 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Jul 14, 2020 11:43 pm ET
Zynex, Inc. Prices Public Offering of Common Stock
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten public offering of an aggregate of 2,500,000 shares of its common stock at a public offering price of $22.00 per share. In the offering, 1,250,000 shares of common stock are being sold by Zynex and 1,250,000 shares of common stock are bei
Jul 14, 2020 04:10 pm ET
Zynex Inc. Announces Proposed Public Offering of Common Stock
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it is commencing an underwritten public offering of shares of its common stock. Zynex and certain of its stockholders are proposing to sell shares of its common stock in the proposed offering.  In addition, Zynex and the selling stockholders intend to grant the underwriters a 30-day op
Jul 09, 2020 09:15 am ET
Zynex Announces 37% Order Growth and Increases Q2 and Full-Year Revenue Estimates
ENGLEWOOD, Colo., July 9, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q2 and the full-year 2020.
Jun 10, 2020 05:51 pm ET
Zynex Set to Join S&P SmallCap 600
NEW YORK, June 10, 2020 /PRNewswire/ -- Zynex Inc. (NASD:ZYXI) will replace KEMET Corp. (NYSE:KEM) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, June 16. Yageo Corp. is acquiring KEMET in a deal expected to be completed on or about June 15 pending final conditions.
May 18, 2020 09:11 am ET
Zynex Announces New Line of Products
ENGLEWOOD, Colo., May 18, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has introduced a full catalog of physical therapy products for distribution through its US sales force.
Apr 28, 2020 04:02 pm ET
Zynex Announces 2020 First Quarter Earnings
ENGLEWOOD, Colo., April 28, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2020.
Apr 21, 2020 09:20 am ET
Zynex Schedules 2020 First Quarter Earnings
ENGLEWOOD, Colo., April 21, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company's 2020 first quarter investor webcast on Tuesday, April 28, 2020 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Apr 07, 2020 09:24 am ET
Zynex Announces 126% Order Growth and Increases Q1 and Full-Year Revenue Estimates
ENGLEWOOD, Colo., April 7, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020.
Mar 30, 2020 09:15 am ET
Zynex Appoints Rachelle Van Burkleo Vice President of Sales
ENGLEWOOD, Colo., March 30, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that it has hired Rachelle (Chelle) Van Burkleo as its Vice President of Sales.
Nov 14, 2019 08:21 am ET
Zynex Ranked 18th in Revenue Growth Among Medical Device Companies
ENGLEWOOD, Colo., Nov. 14, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has been ranked 18th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte's 2019 Technology Fast 500.  Zynex was ranked 488th for revenue growth between 2015 and 2018 across all companies in North America.  Zynex's revenues grew 174% over that period, with 2018
Oct 29, 2019 04:01 pm ET
Zynex Announces 2019 Third Quarter Financial Results
ENGLEWOOD, Colo., Oct. 29, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its third quarter ended September 30, 2019.
Oct 17, 2019 09:20 am ET
Zynex Schedules 2019 Third Quarter Earnings
ENGLEWOOD, Colo., Oct. 17, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company's 2019 third quarter investor webcast on Tuesday, October 29, 2019 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Oct 02, 2019 09:16 am ET
Zynex Announces 95% Order Growth
ENGLEWOOD, Colo., Oct. 2, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced 95% year over year order growth for the third quarter 2019.
Jul 31, 2019 04:04 pm ET
Zynex Announces 2019 Second Quarter Earnings
ENGLEWOOD, Colo., July 31, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended June 30, 2019.
Jul 23, 2019 09:11 am ET
Zynex Recognized as The Fastest Growing Public Company in Colorado based on Net Income
ENGLEWOOD, Colo., July 23, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced the Denver Business Journal has recognized Zynex as Colorado's fastest growing public company based on Net Income Growth in its July 2019 issue. Zynex's Net Income grew 13,743% between 2016 and 2018.
Jul 22, 2019 09:22 am ET
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
ENGLEWOOD, Colo., July 22, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that it has hired Joseph Papandrea as its Chief Operating Officer (COO). As COO Mr. Papandrea will lead operations including billing, patient support, sales and device production.
Jul 16, 2019 09:10 am ET
Zynex Schedules 2019 Second Quarter Earnings
ENGLEWOOD, Colo., July 16, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company's 2019 second quarter investor webcast on Wednesday, July 31, 2019 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Jul 01, 2019 09:15 am ET
Zynex Included in the Russell 2000® Index
ENGLEWOOD, Colo., July 1, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has been included in the Russell 2000 Index following  reconstitution of Russell indices on June 28th.  Zynex will be officially listed on the Index when the markets open on Monday July 1, 2019.
Apr 30, 2019 04:04 pm ET
Zynex Announces 2019 First Quarter Earnings
ENGLEWOOD, Colo., April 30, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2019.
Apr 25, 2019 04:02 pm ET
Zynex Schedules 2019 First Quarter Earnings
ENGLEWOOD, Colo., April 25, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company's 2019 first quarter investor webcast on Tuesday, April 30, 2019 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Mar 26, 2019 09:00 am ET
Zynex to Present at the Spring Investor Summit on April 2nd in New York City at the Essex House
ENGLEWOOD, CO / ACCESSWIRE / March 26, 2019 / Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that Thomas Sandgaard, Chief Executive Officer of Zynex will be presenting at this year's Spring Investor Summit on Tuesday April, 2, 2019 at 2:00 pm EDT in New York City.
Mar 19, 2019 09:12 am ET
Zynex Reactivates Medicare Provider Number in Effort to Accelerate Growth
ENGLEWOOD, Colo., March 19, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has reactivated its Medicare Provider Number in an effort to also bill Medicare on behalf of its patients.
Mar 12, 2019 09:14 am ET
Zynex Expands Corporate Headquarters to Accommodate Growth
ENGLEWOOD, Colo., March 12, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has signed an addendum to its corporate headquarters building lease expanding the footprint to 63,000 square feet, a 50% increase.
Feb 28, 2019 08:25 am ET
Zynex names new Vice President of Sales and Marketing
ENGLEWOOD, Colo., Feb. 28, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced it has hired Christopher A. Brown as its Vice President of Sales and Marketing.
Feb 26, 2019 03:01 pm ET
Zynex Announces 2018 Fourth Quarter and Full Year Earnings
ENGLEWOOD, Colo., Feb. 26, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its fourth quarter and full year ended December 31, 2018.
Feb 20, 2019 08:19 am ET
Zynex Schedules 2018 and Fourth Quarter Earnings
ENGLEWOOD, Colo., Feb. 20, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company's 2018 fourth quarter and full year investor webcast on Tuesday, February 26, 2019 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.)
Feb 14, 2019 08:10 am ET
Zynex to Ring the Nasdaq Stock Market Opening Bell to Celebrate Its Listing
ENGLEWOOD, Colo., Feb. 14, 2019 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces that it will be ringing the Nasdaq Opening Bell at Times Square in New York on Thursday, February 21, 2019. 
Feb 07, 2019 11:41 am ET
Zynex Announces Uplisting to The Nasdaq Capital Market
ENGLEWOOD, Colo., Feb. 7, 2019 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, is pleased to announce that its common shares have been approved to list on The Nasdaq Capital Market and is expected to begin trading under its existing symbol (ZYXI) on February 12, 2019.
Nov 06, 2018 08:11 am ET
Zynex Announces 2018 Third Quarter Earnings and Special Dividend
ENGLEWOOD, Colo., Nov. 6, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its third quarter ended September 30, 2018 and a one-time special cash dividend to its shareholders.
Nov 02, 2018 09:25 am ET
Zynex Schedules 2018 Third Quarter Earnings Release and Webcast
ENGLEWOOD, Colo., Nov. 2, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2018 third quarter investor webcast on Tuesday, November 6, 2018 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Oct 08, 2018 09:21 am ET
Zynex Obtains U.S. Patent for Blood Volume Monitor
ENGLEWOOD, Colo., Oct. 8, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announces that it has obtained a U.S. utility patent for its Blood Volume Monitor Device. Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.
Sep 25, 2018 09:21 am ET
Zynex to Present at the Ladenburg Thalmann 2018 Healthcare Conference
ENGLEWOOD, Colo., Sept. 25, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, and neurological diagnostics, today announced that Thomas Sandgaard, Chief Executive Officer of Zynex, will be presenting at the Ladenburg Thalmann 2018 Healthcare Conference, on Tuesday October 2, 2018 at 2:30 pm EDT.  The conference will be held at the Sofitel Hotel in New York City.
Aug 28, 2018 09:10 am ET
Zynex to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
ENGLEWOOD, Colo., Aug. 28, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), An innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, and neurological diagnostics, today announced that it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co. LLC.  The conference is being held September 4-6, 2018 at the St. Regis Hotel in New York City. 
Aug 02, 2018 08:50 am ET
Zynex Announces 2018 Second Quarter Earnings
ENGLEWOOD, Colo., Aug. 2, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended June 30, 2018.
Jul 27, 2018 09:21 am ET
Zynex Schedules 2018 Second Quarter Earnings Release and Webcast
LONE TREE, Colo., July 27, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2018 second quarter investor webcast on Thursday, August 2, 2018 at 11:00 a.m. Mountain Time (1:00 p.m. Eastern Time.)
May 23, 2018 09:16 am ET
Zynex Recognized in Top 100 Public Companies by ColoradoBiz
ENGLEWOOD, Colo., May 23, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurodiagnostic equipment, today announced that ColoradoBiz Magazine has recognized Zynex as a Top100 Public Company in its May/June 2018 issue.
May 14, 2018 09:11 am ET
Zynex Announces Share Buyback Program
ENGLEWOOD, Colo., May 14, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that its board of directors approved a program to buy back an additional $2 million of the Company's common stock.  The new program will commence on May 14, 2018 and is scheduled to terminate on May 13, 2019 or when the $2 million buyback limit is reached. The Company previously re-purchased 495,091
May 08, 2018 09:19 am ET
Zynex Announces 2018 First Quarter Earnings
ENGLEWOOD, Colo., May 8, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2018.
May 01, 2018 09:14 am ET
Zynex Schedules 2018 First Quarter Earnings Release and Webcast
LONE TREE, Colo., May 1, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2018 first quarter investor webcast on Tuesday, May 8, 2018 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Mar 08, 2018 09:00 am ET
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference
NEW YORK, March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies at the 30th Annual ROTH Conference, taking place March 11-14 at The Ritz Carlton in Dana Point, California. 
Mar 06, 2018 12:14 pm ET
Zynex Appoints New Independent Board Member
ENGLEWOOD, Colo., March 6, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the appointment of Joshua R. Disbrow to its Board of Directors and Audit Committee.
Feb 28, 2018 08:05 am ET
Zynex Announces 2017 Fourth Quarter Earnings
ENGLEWOOD, Colo., Feb. 28, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its fourth quarter ended December 31, 2017.
Feb 22, 2018 08:24 am ET
Zynex Schedules 2017 Fourth Quarter and Full Year Earnings Release and Webcast
LONE TREE, Colo., Feb. 22, 2018 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2017 fourth quarter and full year investor webcast on Wednesday, February 28, 2018 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Feb 01, 2018 08:20 am ET
Zynex introduces the NeuroMove™ Device to its expanding sales force
LONE TREE, Colo., Feb. 1, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the introduction of the NeuroMove device into its expanding direct sales force in the US market. The NeuroMove™ is a device designed to aid stroke survivors regain movement using the brain's ability to rewire itself, also known as "neuro-plasticity".
Jan 12, 2018 12:24 pm ET
Zynex Appoints Two New Independent Board of Directors
LONE TREE, Colo., Jan. 12, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the appointment of Michael Cress, and Barry Michaels to its Board of Directors and Audit Committee. Barry Michaels will also serve as Audit Committee Chair.
Jan 08, 2018 08:04 am ET
Zynex Announces 4th Quarter and Year-End Revenue Guidance Update
LONE TREE, Colo., Jan. 8, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced an update to its previously announced revenue estimate for the fourth quarter.
Dec 06, 2017 09:41 am ET
Zynex Announces Share Buyback Program
LONE TREE, Colo., Dec. 6, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that its board of directors approved a program to buy back up to $2 million of the Company's common stock.
Nov 28, 2017 09:39 am ET
Zynex Announces Webinar to Address the US Opioid Epidemic
LONE TREE, Colo., Nov 28, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI) is an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics. The company continues to introduce several new products to its product portfolio in its efforts to address the pain and rehabilitation markets and the current opioid epidemic.
Nov 13, 2017 08:55 am ET
Zynex Announces 2017 Third Quarter Earnings
LONE TREE, Colo., Nov. 13, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its third quarter ended September 30, 2017.
Nov 07, 2017 09:11 am ET
Zynex Schedules 2017 Third Quarter Earnings Release and Webcast
LONE TREE, Colo., Nov. 7, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2017 third quarter investor webcast on Monday, November 13, 2017 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Nov 06, 2017 08:31 am ET
Zynex Presentation Now Available for On-Demand Viewing
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation
Nov 06, 2017 08:31 am ET
Zynex Presentation Now Available for On-Demand Viewing
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation
Oct 30, 2017 11:41 am ET
Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd
Company executives share vision, answer questions live at VirtualInvestorConferences.com
Oct 30, 2017 11:41 am ET
Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd
Company executives share vision, answer questions live at VirtualInvestorConferences.com
Oct 30, 2017 09:31 am ET
Zynex to Webcast, Live, at VirtualInvestorConferences.com November 2nd
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
Oct 30, 2017 09:31 am ET
Zynex to Webcast, Live, at VirtualInvestorConferences.com November 2nd
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
Oct 27, 2017 10:22 am ET
Zynex Growth Leads to a New Corporate Headquarters
LONE TREE, Colo., Oct. 27, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it has leased new office space and will be moving its corporate headquarters to 9555 Maroon Circle, Englewood CO 80112.
Sep 21, 2017 10:05 am ET
Zynex to Present at the SeeThruEquity Disruptive Growth Company Showcase
LONE TREE, Colo., Sept. 21, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that Thomas Sandgaard, Founder and CEO, will present at the SeeThruEquity Disruptive Growth Company Showcase on Wednesday September 27, 2017 at 11:30 am EDT. The conference will be held at the Grand Hyatt in New York City.  Management will also be meeting with members of the investment community during o
Sep 18, 2017 12:12 pm ET
Zynex Continues Fight Against Opioid Abuse and Expands Its Arsenal of Pain Relief Products
LONE TREE, Colo., Sept. 18, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics.  The company continues to introduce several new products to its product portfolio in its efforts to address the pain and rehabilitation markets and the current opioid epidemic.
Sep 11, 2017 10:25 am ET
Zynex to Present at the Rocky Mountain MicroCap Conference in Denver on September 25, 2017
LONE TREE, Colo., Sept. 11, 2017 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will be presenting at the Rocky Mountain MicroCap Conference this month sponsored by GVC Capital and Trickle Research in Denver at Coors Field.
Sep 07, 2017 04:30 pm ET
GVC Capital and Trickle Research Announce Preliminary Presenter Schedule for Inaugural Rocky Mountain MicroCap Conference in Denver on September 25, 2017
GVC Capital LLC ("GVC") and Dave Lavigne at Trickle Research LLC ("Trickle Research") will host the inaugural Rocky Mountain MicroCap Conference on September 25, 2017, in Denver at Coors Field. The Rocky Mountain MicroCap Conference is an investment conference for 13 public microcap companies to present to a large gathering of microcap centric investors.
Sep 06, 2017 10:20 am ET
Zynex Announces Efforts to Address the Opioid Crisis
LONE TREE, Colo., Sept. 6, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced an effort to address the nationwide opioid crisis.
Aug 22, 2017 10:00 am ET
Taglich Brothers Initiates Zynex, Inc.
Taglich Brothers, Inc. announces that it has initiated coverage of Zynex, Inc. (OTCQB: ZYXI).Zynex, Inc., headquartered in Lone Tree, Colorado provides FDA-cleared electrotherapy medical devices used for pain management and rehabilitation. The...
Aug 14, 2017 10:05 am ET
Zynex Announces 2017 Second Quarter Earnings
LONE TREE, Colo., Aug. 14, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended June 30, 2017.
Aug 07, 2017 10:16 am ET
Zynex Schedules 2017 Second Quarter Earnings Release and Webcast
LONE TREE, Colo., Aug. 7, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2017 second quarter investor webcast on Monday, August 14, 2017 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Jul 06, 2017 10:14 am ET
Zynex Pays Off Loan Balance
LONE TREE, Colo., July 6, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today that it has paid off the entire remaining loan balance to Triumph Healthcare Finance.
Jun 19, 2017 10:21 am ET
Zynex Recognized in Top 100 Public Companies by ColoradoBiz
LONE TREE, Colo., June 19, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neurodiagnostic equipment, cardiac and blood volume monitoring, announces today that ColoradoBiz Magazine has recognized Zynex in Top100 Public Companies in its May/June 2017 issue.
Jun 09, 2017 10:12 am ET
Zynex Hires Chief Financial Officer
LONE TREE, Colo., June 9, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces the appointment of Dan Moorhead as its Chief Financial Officer.
May 15, 2017 10:05 am ET
Zynex Announces 2017 First Quarter Results
LONE TREE, Colo., May 15, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces 2017 first quarter financial results.
May 12, 2017 10:25 am ET
Zynex Schedules 2017 First Quarter Earnings Release and Webcast
LONE TREE, Colo., May 12, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2017 first quarter investor webcast on Monday, May 15, 2017 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Apr 03, 2017 11:55 am ET
Zynex Announces 2016 Year End Results
LONE TREE, Colo., April 3, 2017 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces 2016 year-end financial results.
Mar 29, 2017 12:33 pm ET
Zynex Schedules 2016 Earnings Release and Webcast
LONE TREE, Colo., March 29, 2017 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company's 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time.)
Dec 29, 2016 08:30 am ET
Zynex General Update and November Orders
LONE TREE, Colo., Dec. 29, 2016 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring, announces update on November orders, fourth quarter estimate, loan forbearance agreement and a request from the US Army to participate in its Hemorrhage Detection project with the Zynex Blood Volume Monitor.
Nov 10, 2016 08:55 am ET
Zynex Announces Third Quarter 2016 Profit
LONE TREE, Colo., Nov. 10, 2016 /PRNewswire/ -- Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring, announced today its third quarter 2016 financial results.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.